Home Navigating the global supply of starting materials for cell-based therapies

Navigating the global supply of starting materials for cell-based therapies

Elena Meurer & Jennifer Sales

The use of biological starting materials in the development of allogeneic cell-based therapies poses several challenges, whether due to availability of appropriate donors, complicated global logistics, or lack of global regulatory harmonisation around technical testing requirements

Go Back

Start a conversation today

Socials:

First Name*

Last Name*

Telephone

Country

Company Name*

Email*

Your message

Please tick this box to agree to our Privacy Policy.*

Please tick this box if you agree to periodic updates from Biopharma Excellence. If you do not wish to receive any communication from us, you may unsubscribe at any time.